Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo

Blood

Volumn 125, Issue 9, 2015, Pages 1502-1506

  Parmar, Simrit ^a   Liu, Xiaoying ^a   Najjar, Amer ^a   Shah, Nina ^a   Yang, Hong ^a   Yvon, Eric ^a   Rezvani, Katy ^a   McNiece, Ian ^a   Zweidler McKay, Patrick ^a   Miller, Leonard ^b   Wolpe, Steve ^b   Blazar, Bruce R ^c   Shpall, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Targazyme Inc   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 FUCOSYLTRANSFERASE; ALPHA 1,3 FUCOSYLTRANSFERASE VI; FUCOSE; P SELECTIN GLYCOPROTEIN LIGAND 1; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; GALACTOSIDE 3-FUCOSYLTRANSFERASE; MEMBRANE PROTEIN; OLIGOSACCHARIDE; P-SELECTIN LIGAND PROTEIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROL STRATEGY; CONTROLLED STUDY; EX VIVO STUDY; FUCOSYLATION; GRAFT VERSUS HOST REACTION; HUMAN; IN VIVO STUDY; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; FEMALE; FETUS BLOOD; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; IMMUNOLOGY; METABOLISM; MORTALITY; NONOBESE DIABETIC MOUSE; SCID MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; E-SELECTIN; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; FUCOSE; FUCOSYLTRANSFERASES; GRAFT VS HOST DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; OLIGOSACCHARIDES; T-LYMPHOCYTES, REGULATORY;

EID: 84982091033     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-10-603449     Document Type: Article

References (18)

1. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14):3921-3928.
2. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3): 1061-1070.
3. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493-3499.
4. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196(3):389-399.
5. Edinger M, Hoffmann P, Ermann J, et al. CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9(9):1144-1150.
6. Cao T, Soto A, Zhou W, et al. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). Cell Immunol. 2009;258(1):65-71.
7. Mutis T, van Rijn RS, Simonetti ER, et al. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Clin Cancer Res. 2006;12(18):5520-5525.
8. Rieger K, Loddenkemper C, Maul J, et al. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood. 2006; 107(4):1717-1723.
9. Mohty M, Gaugler B. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation. Cytokine Growth Factor Rev. 2008;19(1):53-63.
10. Siegmund K, Feuerer M, Siewert C, et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood. 2005;106(9):3097-3104.
11. Matsuda Y, Hara J, Osugi Y, et al. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant. 2001;27(9):977-982.
12. Ohmori K, Fukui F, Kiso M, et al. Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells. Blood. 2006;107(8):3197-3204.
13. Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011;118(26): 6743-6751.
14. Robinson SN, Thomas MW, Simmons PJ, et al. Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment. Cytotherapy. 2014;16(1):84-89.
15. Popat UR, Oran B, Hosing CM, et al. Ex vivo fucosylation of cord blood accelerates neutrophil and platelet engraftment [abstract]. Blood. 2013; 122(21). Abstract 691.
16. Parmar S, Liu X, Tung SS, et al. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease. Cytotherapy. 2014;16(1):90-100.
17. Sato T, Deiwick A, Raddatz G, Koyama K, Schlitt HJ. Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immunol. 1999;115(2):301-308.
18. Reddy V, Hill GR, Pan L, et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation. 2000;69(4): 691-693.